Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.8000
-0.0452 (-5.35%)
May 19, 2026, 4:00 PM EDT - Market closed
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $9.59 million as of May 19, 2026. Its market cap has decreased by -0.86% in one year.
Market Cap
9.59M
Enterprise Value
-36.88M
1-Year Change
-0.86%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $9.59M, a decrease of -49.37%. That is a compound annual growth rate of -15.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 9.59M | 60.69% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioCardia | 10.40M |
| Kairos Pharma | 10.23M |
| BioVie | 9.88M |
| CalciMedica | 9.72M |
| MetaVia | 9.71M |
| Quoin Pharmaceuticals | 9.32M |
| Lunai Bioworks | 9.08M |
| Bolt Biotherapeutics | 9.07M |